Prilenia: Prilenia Therapeutics B.V.: Prilenia Announces Clinical Data in Support of its Plans to Initiate Global Phase 3 Study in ALS

Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelo...